Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
6 participants
INTERVENTIONAL
2018-01-15
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Peel Force of New Adhesives From the Skin
NCT03200444
Evaluation of the Influence of New Adhesives of Output on Skin
NCT03044262
Assessement of the Peal Force Needed to Peel New Adhesives From the Skin
NCT03289013
Evaluation of the Performance of an Adhesive Strip
NCT03419013
A Pilot Evaluation of Adhesives and How They Are Impacted by Output
NCT02886442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Introduction to the study
* Inclusion in study
* Baseline information is obtained
* Instruct subject to pre-strip of abdominal skin
Test visits 1-25 (up to maximum 25 visits per subject. (1-3 days after pre-stripping the abdominal skin):
* Baseline measurements are conducted on both sides of the stomach (TEWL, hydration, erythema, pH - 3 repeated measurements under each adhesive strip area (upper, middle and bottom of adhesive strip)
* Potential wetting of skin - shower/bicycle exercise (max 60 minutes) and after-wetting baseline measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Adhesive strips are weighted and applied
* Potential shower/bicycle exercise (max 60 minutes)
* Adhesive strips are removed at pre-defined timeslots (peel force measured)
* Discomfort when strip was peeled of is evaluated by subject (VAS)
* Measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Acclimatization ½
* Measurements are conducted (TEWL, hydration, erythema, pH - 3 times/strips (upper, middle and bottom of adhesive strip))
* Adhesive strips are weighed
* Photo of adhesive strips
The subjects can be asked to apply and change strips every 24 hours between two test visits but for a maximum of 10 days between two visits. The strips should be applied at the same place every time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test of new adhesive strips
The subjects will test adhesives strips made of 4 different adhesives:
Standard adhesive 1 Standard adhesive 2 PL4 PL16-L
Standard adhesive 1
This strip contains a standard hydrocolloid adhesive found in ostomy devices
Standard adhesive 2
This strip contains a standard hydrocolloid adhesive found in ostomy devices
PL4
This strip contains a new adhesive
PL16-L
This strip contains a new adhesive
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard adhesive 1
This strip contains a standard hydrocolloid adhesive found in ostomy devices
Standard adhesive 2
This strip contains a standard hydrocolloid adhesive found in ostomy devices
PL4
This strip contains a new adhesive
PL16-L
This strip contains a new adhesive
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be at least 18 years of age and have full legal capacity
3. Have intact skin on the area used in the investigation
Exclusion Criteria
2. Currently receiving or have within the past months received topical steroid treatment in the abdominal skin area or systemic steroid (tablet/injection) treatment.
3. Are pregnant or breastfeeding
4. Have dermatological problems in the abdominal area (assessed by investigator)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lene F Nielsen
Role: PRINCIPAL_INVESTIGATOR
Head of the pre-clinical department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coloplast A/S
Humlebæk, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP267_3_5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.